Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy

Analytical and Bioanalytical Chemistry

Volumn 404, Issue 10, 2012, Pages 3101-3109

  Hirayama, Akiyoshi ^a   Nakashima, Eitaro ^b,c   Sugimoto, Masahiro ^d   Akiyama, Shin Ichi ^c   Sato, Waichi ^c   Maruyama, Shoichi ^c   Matsuo, Seiichi ^c   Tomita, Masaru ^a   Yuzawa, Yukio ^c   Soga, Tomoyoshi ^a  

^a KEIO UNIVERSITY   (Japan)

^b CHUBU ROSAI HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Capillary electrophoresismass spectrometry; Diabetic nephropathy; Metabolome; Multiple logistic regression; Orthogonal partial least squares discriminant analysis

Indexed keywords

CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRIES; DIABETIC NEPHROPATHY; METABOLOMES; MULTIPLE LOGISTIC REGRESSION; PARTIAL LEAST SQUARES;

AMINO ACIDS; BIOMOLECULES; BODY FLUIDS; CAPILLARY ELECTROPHORESIS; DISCRIMINANT ANALYSIS; DISEASES; LOGISTICS; MASS SPECTROMETRY; METABOLITES; MULTIVARIANT ANALYSIS; STATISTICAL TESTS;

BIOMARKERS;

BIOLOGICAL MARKER;

AGED; ARTICLE; BLOOD; CAPILLARY ELECTROPHORESIS; DIABETIC NEPHROPATHY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY;

AGED; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; DISCRIMINANT ANALYSIS; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE;

EID: 84870947792     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6412-x     Document Type: Article

References (27)

1. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28(1):164-176
2. Kim HJ, Cho EH, Yoo JH, Kim PK, Shin JS, Kim MR, Kim CW (2007) Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 6(2):735-743
3. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW (2004) Nephropathy in diabetes. Diabetes Care 27(Suppl 1):S79-S83
4. Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH (2001) Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24(9):1560-1566
5. Dihazi H, Muller GA, Lindner S, Meyer M, Asif AR, Oellerich M, Strutz F (2007) Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem 53(9):1636-1645
6. Mischak H, Kaiser T,Walden M, Hillmann M,Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D (2004) Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 107(5):485-495
7. Tiziani S, Lopes V, Gunther UL (2009) Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 11(3):269-276
8. Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363(2):185-195
9. Sieber M, Wagner S, Rached E, Amberg A, Mally A, Dekant W (2009) Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery. Chem Res Toxicol 22(7):1221-1231
10. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69(11):4918-4925
11. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, Kakazu Y, Ishikawa T, Robert M, Nishioka T, Tomita M (2006) Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281(24):16768-16776
12. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M (2010) Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6(1):78-95
13. Xia JF, Liang QL, Hu P, Wang YM, Li P, Luo GA (2009) Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients. Clin Biochem 42(3):215-220
14. Jiang Z, Liang Q, Luo G, Hu P, Li P, Wang Y (2009) HPLCelectrospray tandemmass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy. Talanta 77(4):1279-1284
15. Zhang J, Yan L, ChenW, Lin L, Song X, Yan X, HangW, Huang B (2009) Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal Chim Acta 650(1):16-22
16. Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T (2003) Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res 2(5):488-494
17. Soga T, Igarashi K, Ito C, Mizobuchi K, Zimmermann HP, Tomita M (2009) Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal Chem 81(15):6165- 6174
18. Witten I, Frank E (2000) Data mining: practical machine learning algorithms with Java implementations. Morgan Kaufmann Publishers, CA
19. Xia JF, Liang QL, Liang XP, Wang YM, Hu P, Li P, Luo GA (2009) Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy. J Chromatogr B Analyt Technol Biomed Life Sci 877(20-21):1930-1936
20. Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38(10):1933-1953
21. Chuang CK, Lin SP, Chen HH, Chen YC, Wang TJ, Shieh WH, Wu CJ (2006) Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Clin Chim Acta 364(1-2):209-216
22. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G (2001) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int 59:S14-S18
23. Pahlich S, Zakaryan RP, Gehring H (2006) Protein arginine methylation: cellular functions and methods of analysis. Biochim Biophys Acta 1764(12):1890-1903
24. Saito K, Fujigaki S, Heyes MP, Shibata K, Takemura M, Fujii H, Wada H, Noma A, Seishima M (2000) Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. American Journal of Physiology-Renal Physiology 279(3):F565
25. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T (2010) Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33 (9):944-952
26. Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y (1991) Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 283(3):162-166
27. Watanabe S, Yamada M, Ohtsu I, Makino K (2007) α-Ketoglutaric semialdehyde dehydrogenase isozymes involved in metabolic pathways of D-glucarate, D-galactarate, and hydroxy-L-proline. J Biol Chem 282(9):6685